Rebecca G Fortgang, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Gambling | 3 | 2020 | 258 | 1.140 |
Why?
|
| Suicidal Ideation | 11 | 2024 | 1447 | 1.080 |
Why?
|
| Impulsive Behavior | 2 | 2018 | 346 | 0.940 |
Why?
|
| Psychotic Disorders | 5 | 2024 | 3219 | 0.660 |
Why?
|
| Schizophrenic Psychology | 4 | 2020 | 1644 | 0.650 |
Why?
|
| Schizophrenia | 6 | 2020 | 6929 | 0.570 |
Why?
|
| Endophenotypes | 2 | 2016 | 255 | 0.560 |
Why?
|
| Suicide | 5 | 2024 | 1601 | 0.480 |
Why?
|
| Motivation | 3 | 2020 | 2003 | 0.450 |
Why?
|
| Self-Injurious Behavior | 2 | 2024 | 566 | 0.280 |
Why?
|
| Cognition | 3 | 2022 | 6987 | 0.250 |
Why?
|
| Suicide, Attempted | 2 | 2024 | 1402 | 0.240 |
Why?
|
| Diseases in Twins | 2 | 2016 | 446 | 0.230 |
Why?
|
| Substance-Related Disorders | 2 | 2018 | 4414 | 0.210 |
Why?
|
| Registries | 2 | 2016 | 8236 | 0.180 |
Why?
|
| Self Efficacy | 1 | 2024 | 636 | 0.180 |
Why?
|
| Bipolar Disorder | 2 | 2016 | 5091 | 0.170 |
Why?
|
| International Classification of Diseases | 1 | 2024 | 913 | 0.160 |
Why?
|
| Self-Assessment | 1 | 2021 | 399 | 0.160 |
Why?
|
| Ethics, Research | 1 | 2020 | 176 | 0.150 |
Why?
|
| Depressive Disorder, Major | 1 | 2016 | 4766 | 0.150 |
Why?
|
| Recreation | 1 | 2018 | 125 | 0.150 |
Why?
|
| Sweden | 2 | 2016 | 1379 | 0.130 |
Why?
|
| Adult | 20 | 2024 | 221083 | 0.130 |
Why?
|
| Delusions | 1 | 2017 | 298 | 0.120 |
Why?
|
| Thinking | 1 | 2017 | 319 | 0.120 |
Why?
|
| Models, Statistical | 3 | 2024 | 5077 | 0.110 |
Why?
|
| Behavior, Addictive | 1 | 2018 | 462 | 0.100 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 2022 | 1081 | 0.100 |
Why?
|
| Consciousness | 1 | 2017 | 600 | 0.100 |
Why?
|
| Patient Discharge | 2 | 2021 | 3441 | 0.090 |
Why?
|
| Inpatients | 1 | 2022 | 2545 | 0.090 |
Why?
|
| Perception | 1 | 2017 | 1198 | 0.090 |
Why?
|
| Decision Making | 1 | 2024 | 3925 | 0.090 |
Why?
|
| Male | 17 | 2024 | 360675 | 0.090 |
Why?
|
| Cognition Disorders | 2 | 2016 | 3974 | 0.080 |
Why?
|
| Female | 17 | 2024 | 392458 | 0.080 |
Why?
|
| Humans | 25 | 2024 | 761098 | 0.080 |
Why?
|
| Middle Aged | 12 | 2024 | 220835 | 0.080 |
Why?
|
| Young Adult | 7 | 2024 | 59199 | 0.080 |
Why?
|
| Psychiatry | 1 | 2020 | 1692 | 0.070 |
Why?
|
| Electronic Health Records | 1 | 2024 | 4813 | 0.070 |
Why?
|
| Neuropsychological Tests | 1 | 2020 | 7043 | 0.070 |
Why?
|
| Severity of Illness Index | 2 | 2020 | 15845 | 0.060 |
Why?
|
| Belgium | 1 | 2024 | 118 | 0.060 |
Why?
|
| Hospitalization | 2 | 2022 | 10712 | 0.060 |
Why?
|
| Adolescent | 5 | 2024 | 88271 | 0.060 |
Why?
|
| Amyloid beta-Peptides | 1 | 2016 | 3840 | 0.050 |
Why?
|
| Psychological Theory | 1 | 2024 | 175 | 0.050 |
Why?
|
| Telemedicine | 1 | 2020 | 3051 | 0.050 |
Why?
|
| Consensus | 1 | 2012 | 3133 | 0.050 |
Why?
|
| Intention | 1 | 2023 | 347 | 0.040 |
Why?
|
| Models, Psychological | 1 | 2024 | 828 | 0.040 |
Why?
|
| Iatrogenic Disease | 1 | 2022 | 539 | 0.040 |
Why?
|
| Privacy | 1 | 2020 | 233 | 0.040 |
Why?
|
| Twins, Dizygotic | 1 | 2016 | 236 | 0.030 |
Why?
|
| Communicable Disease Control | 1 | 2022 | 846 | 0.030 |
Why?
|
| Aftercare | 1 | 2021 | 913 | 0.030 |
Why?
|
| Psychiatric Status Rating Scales | 2 | 2018 | 6011 | 0.030 |
Why?
|
| Twins, Monozygotic | 1 | 2016 | 470 | 0.030 |
Why?
|
| Psychometrics | 2 | 2016 | 3061 | 0.030 |
Why?
|
| Affect | 1 | 2022 | 1486 | 0.030 |
Why?
|
| Time Factors | 3 | 2023 | 39953 | 0.030 |
Why?
|
| Finland | 1 | 2016 | 607 | 0.030 |
Why?
|
| Chemokine CCL2 | 1 | 2016 | 602 | 0.030 |
Why?
|
| Twins | 1 | 2016 | 340 | 0.030 |
Why?
|
| Informed Consent | 1 | 2020 | 1007 | 0.030 |
Why?
|
| Microarray Analysis | 1 | 2016 | 748 | 0.030 |
Why?
|
| Age of Onset | 1 | 2018 | 3307 | 0.020 |
Why?
|
| Statistics as Topic | 1 | 2016 | 2359 | 0.020 |
Why?
|
| Emotions | 1 | 2021 | 2740 | 0.020 |
Why?
|
| Health Status | 1 | 2022 | 4077 | 0.020 |
Why?
|
| Hospitals | 1 | 2022 | 3881 | 0.020 |
Why?
|
| Factor Analysis, Statistical | 1 | 2012 | 998 | 0.020 |
Why?
|
| Cross-Sectional Studies | 2 | 2022 | 26068 | 0.020 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2016 | 1837 | 0.020 |
Why?
|
| Longitudinal Studies | 1 | 2024 | 14607 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2021 | 8639 | 0.020 |
Why?
|
| Ambulatory Care | 1 | 2018 | 2769 | 0.020 |
Why?
|
| Self Report | 1 | 2018 | 3728 | 0.020 |
Why?
|
| Reproducibility of Results | 1 | 2024 | 20120 | 0.020 |
Why?
|
| Memory | 1 | 2016 | 2190 | 0.020 |
Why?
|
| RNA | 1 | 2016 | 2708 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2018 | 17889 | 0.020 |
Why?
|
| Algorithms | 1 | 2024 | 14023 | 0.010 |
Why?
|
| Risk Factors | 2 | 2022 | 74219 | 0.010 |
Why?
|
| Incidence | 1 | 2022 | 21357 | 0.010 |
Why?
|
| Pandemics | 1 | 2022 | 8663 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2024 | 41486 | 0.010 |
Why?
|
| Prognosis | 1 | 2021 | 29672 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2016 | 9416 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 2016 | 11856 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2016 | 12670 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2024 | 80673 | 0.010 |
Why?
|
| Aged | 1 | 2016 | 169266 | 0.000 |
Why?
|